journal
MENU ▼
Read by QxMD icon Read
search

Oncology (Williston Park, NY)

journal
https://read.qxmd.com/read/31571185/fda-approved-uses-of-cabozantinib
#1
Jennifer Leavitt, Mehmet Sitki Copur
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571184/practical-dosing-considerations-for-venetoclax
#2
Kelly Valla
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571183/therapy-options-for-patients-with-hepatocellular-carcinoma
#3
Crystal Denlinger
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571182/biliary-cancer-current-multimodality-treatment-and-future-directions
#4
Mehmet Sitki Copur, Shaheed Merani, Luciano M Vargas
Biliary cancer is a highly aggressive malignancy arising from the biliary tree, with its incidence increasing steadily on a global level. Most biliary cancers are diagnosed in the advanced and metastatic stages due to the paucity of signs and symptoms in the early presentation. Only about one-third of the patients can be treated with curative intent with an overall median survival of less than 24 months for all-comers from the time of diagnosis. This fact and the poor results of the currently available local and systemic therapies, are responsible for the disappointing outcome of biliary cancer patients...
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571181/drugs-in-the-pipeline-non-small-cell-lung-cancer
#5
Naveed Saleh
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571180/clinical-trials-in-breast-and-endometrial-cancer
#6
Anna Azvolinsky, Joanna Pangilinan
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571179/67-year-old-male-with-prostatic-stromal-tumor-of-uncertain-malignant-potential
#7
Luke Bidikov, Paul Maroni, Simon Kim, E David Crawford
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31571178/game-changers-in-treatment-of-hematologic-malignancies
#8
Andre Goy
No abstract text is available yet for this article.
September 20, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469905/monitoring-for-thyroid-cancer-recurrence
#9
Alan N Peiris
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469904/current-clinical-trials-in-prostate-cancer
#10
Naveed Saleh
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469903/gilteritinib-changes-aml-landscape
#11
Naveed Saleh
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469902/atezolizumab-and-its-many-uses
#12
Naveed Saleh, Mehmet Sitki Copur
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469901/universal-genetic-testing-for-all-breast-cancer-patients
#13
Mehmet Sitki Copur
Women with pathogenic BRCA1/2 mutations are more likely to develop breast cancer than are women without the mutation and they typically develop cancer at an earlier age. If women are aware of their BRCA1/2 status, however, they can make timely decisions about preventive measures such as chemoprevention with hormonal agents or undergoing prophylactic surgery, all of which have been shown to reduce the risk of cancer and overall mortality. The US Preventive Services Task Force and the National Comprehensive Cancer Network have recommended that women with a family history of breast, ovarian, and certain other cancers consider BRCA1/2 testing...
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469900/what-are-treatment-options-after-progression-in-pdl-1-positive-metastatic-lung-adenocarcinoma-after-chemo-io
#14
Yuly A Remolina-Bonilla, Raul R Trejo-Rosales, Bruno Saldivar-Oviedo, Alejandro Gabutti, Maria T Bourlon
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469899/management-of-steroid-refractory-immune-related-adverse-events
#15
Marley L Watson, Tyler Beardslee
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469898/pediatric-acute-lymphoblastic-leukemia
#16
Susan R Rheingold
No abstract text is available yet for this article.
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31469897/targeting-the-sanctuary-site-options-when-breast-cancer-metastasizes-to-the-brain
#17
Mridula Krishnan, Jairam Krishnamurthy, Nicole Shonka
Brain metastasis is a poor prognostic factor in breast cancer progression, and traditional treatment options have shown minimal response with overall low median survival rates. The incidence of brain metastasis has been increasing despite and, in part, due to advancements in treatment as a result of prolongation of survival. Targeted therapy such anti-HER2 agents have a lower efficacy in this setting compared to metastases elsewhere; however, novel therapies are emerging in this regard. In this comprehensive review, we discuss risk per subtype, special considerations for therapy selection, current focal and systemic treatments, and recent advancements and potential future targets for success...
August 23, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31365754/diffuse-hepatic-infiltration-by-metastatic-melanoma
#18
Hugo E Velázquez, Francisco J Castro-Alonso, Christianne Bourlon, Alejandro Gabutti, Cecilia Gallegos, María T Bourlon
No abstract text is available yet for this article.
July 16, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31365753/therapy-options-in-treating-acute-lymphoblastic-leukemia-in-adults
#19
Elias Jabbour
No abstract text is available yet for this article.
July 16, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31365752/multiple-primary-tumors-over-a-lifetime
#20
Mehmet Sitki Copur, Suresh Manapuram
The frequency of patients living after a cancer diagnosis continues to increase due to the rising incidence of cancer as well as the improved survival of cancer patients thanks to advances in cancer research and treatment. The risk of multiple primary cancers is also increasing due to increasing numbers of cancer survivors, long-term side effects of chemotherapy and/or radiation therapy, increased diagnostic sensitivity, and persisting effects of genetic and behavioral risk factors. Multiple primary cancers are defined as more than one synchronous or metachronous cancer in the same individual...
July 16, 2019: Oncology (Williston Park, NY)
journal
journal
29689
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"